Tekton Research is a multi-specialty investigator network with sites located in Colorado, Georgia, Kansas, North Carolina, Oklahoma, and Texas.
Tekton clinical teams have a reputation for delivering high-quality data and predictable enrollment for clinical, diagnostic, and device trials alike. Whether you are seeking a single-site solution or a network of sites for your trial, Tekton will ensure you have the right solutions to execute your study.
Chief Executive Officer (CEO)
Kip McKenzie is the founder and CEO of Tekton Research. Kip has been in the pharmaceutical research industry for 30+ years. He leveraged the knowledge he gained throughout his career to develop an exceptional research company that focuses on quality and ethical research. Kip championed bold initiatives to build a premier and sought-after site network for vaccine and specialty research. His business acumen led him to develop a strategic and unique business model that allows the company to grow organically and steadily with sustainable financial risk.
Chief Operating Officer (COO)
Russell joined Tekton as Chief Operating Officer in 2023 and oversees the daily operations of the business and supports the growth, financial, and strategic initiatives. He joins with over 20 years of international research experience. Prior to joining Tekton, Russell held several executive positions, including most recently as Vice President, Head of Frenova Renal Research. Frenova is the site network services of Fresenius Medical Care and is the largest provider of patients and sites in the Nephrology community. Russell earned a Bachelor of Science in Management and an MBA from Southern New Hampshire University.
Chief Financial Officer (CFO)
Corey brings nearly 17 years of experience in financial leadership roles. Before joining Tekton Research, Corey contributed significantly to the financial health of organizations in the manufacturing and pharmaceutical industries. He brings experience from successful companies such as American Expediting, Dicalite Management Group, and PCI Pharma Services. Corey’s early career included various financial leadership roles at GE Water & Process Technologies and Deloitte. He earned his bachelor’s degree in accounting from the University of South Carolina and is a Certified Public Accountant in the Commonwealth of Pennsylvania. Corey is already working diligently to position Tekton for growth.
Chief Business Officer (CBO)
Jason has over 20 years of clinical research experience including study coordination, site management, patient recruitment, contract negotiation, and business development. Prior to rejoining Tekton Research in 2022, Jason oversaw all business activities for Platinum Research Network including 7 clinical research site networks and 165+ investigators operating across 21 different medical specialties. Jason has also held leadership roles on behalf of Site Networks, CROs, and Academic Practices. Currently, Jason oversees business development, client relationship management, and site expansion activities for Tekton and is passionate about accelerating drug and vaccine development in the clinical research industry.
Director of Business Development
Lil has enjoyed a lifetime of experience in the medical industry, with over 20 years in clinical research. Her research career started at the University of Calgary and the Calgary Metabolic Education & Research Center, working on diabetes, epidemiological, and clinical research studies as a research photographer, patient recruiter, and study coordinator. She is currently the Director of Business Development at Tekton Research and plays a leading role in establishing new study opportunities and strengthening existing client relationships. Lil joined Tekton Research in 2008 as one of the original staff members and is very passionate about Tekton Research!
Senior Director of Business Development
Blaire has over 12 years of experience in clinical research. She started her career at a large phase I clinic in Austin and then joined Tekton Research in 2014. Blaire has experience in patient recruitment, site management, and study feasibility. She now oversees Tekton’s business development team, feasibility operations, and strategic client relationships. Blaire serves as a central point of contact for all Tekton sites and clients and is determined to build win-win relationships with our clients and partners.
Associate Director of Business Development
Rene opens the line of communication between clients and clinical research sites by gathering and delivering high-quality feasibility and site assessment information. She has over 20 years of experience in project management, strategic implementation, client communications, and business collaboration. Prior to joining Tekton, Rene managed business development activities for Platinum Research Network, representing 7 clinical research site networks including 165+ investigators operating across 21 different medical specialties.
Executive Director of Operations
Alison has over 20 years of phase I-IV clinical research experience. Her research career started at the UT Nursing School working as a research assistant studying health behavior in adolescents. As she moved along in her career, she began working at a phase I research unit in Austin, then finally branched out to phase II-IV research in the areas of vaccine, nephrology, endocrinology, women’s health, and other various indications. Alison’s passion is diabetes and metabolic disease. Alison is currently the Executive Director of Operations at Tekton Research overseeing all operations in five states with a heavy focus on vaccine research.
Medical Director, Principle Investigator
Dr. Paul K. Pickrell is a native Texan with 28 years’ experience providing personalized time to his patients diagnosing and treating rheumatic diseases. He believes that humor blended with professionalism is an important approach to establishing relationships with his patients as it relieves the stress that sometimes accompanies those with auto-immune disease and related conditions.
Dr. Pickrell graduated from Oklahoma City University in 1985 with degrees in chemistry and piano performance. He then attended the University of Oklahoma Medical School followed by an internship and residency at Good Samaritan Hospital in Phoenix AZ.
Strategic Advisor Endocrinology, Principle Investigator
Dr. Pablo F. Mora, an endocrinologist at North Texas Diabetes & Endocrinology and Clinical Professor of Medicine at the University of Texas Southwestern (UTSW) Medical Center, holds a vast array of qualifications and experience. With his educational background from the University of Costa Rica School of Medicine and additional training at UT Southwestern Medical Center, Dr. Mora specializes in diabetes and metabolism. He is a Certified Diabetes Educator and a diplomate of the Diabetes, Endocrinology, and Metabolism Subspecialties Board. Dr. Mora’s clinical interests span from type 1 diabetes transitional programs to research in modern insulin delivery systems and pharmacological interventions for diabetes and non-alcoholic fatty liver disease (NAFLD). Recognized for his excellence in teaching, he has received prestigious awards, including the Daniel Foster Award for Clinical Teaching at UTSW Medical Center.
We manage the study lifecycle from start to finish.
Tekton’s Feasibility team and investigators are committed to providing reliable and timely feedback for site selection. Our sites can operate under a single confidentiality agreement or execute site-specific agreements – your choice!
Tekton sites aim to be your first sites activated and to enroll your first subject. Our dedicated Regulatory and Contract teams collaborate with our ClinOps and Recruitment teams, so we can hit the ground running following the SIV.
Tekton teams pre-identify subjects from our investigators’ private practices, and the local community, prior to the SIV. We deploy cross-channel messaging for visit reminders and check in with subjects between visits.
Tekton sites follow SOPs and QA programs, managed by our dedicated QA team. Procedures are reviewed annually for compliance with current GCP and FDA regulations. Tekton sites are considered “audit ready” at all times.
"*" indicates required fields
All Rights Reserved. Site Designed By:
